Tarantino, P., Li, T., Strickland, C., DeMeo, M., Anderson, L., Pasternak, E., Anders, C. K., Ahluwalia, M. S., Mahtani, R. L., Hsu, L., Ossing, S., Tayob, N., Tolaney, S. M., Lin, N. U., Sammons, S. L. (2025). DATO-Base: A phase II study of DATOpotamab deruxtecan for patients with breast cancer brain metastases or leptomeningeal disease.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps1134